A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder

OBJECTIVE: Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant OCD symptoms. The purpose of this study was to examine the effects of augm...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Simpson, Helen Blair, Foa, Edna B., Liebowitz, Michael R., Ledley, Deborah Roth, Huppert, Jonathan D., Cahill, Shawn, Vermes, Donna, Schmidt, Andrew B., Hembree, Elizabeth, Franklin, Martin, Campeas, Raphael, Hahn, Chang-Gyu, Petkova, Eva
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2008
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3945728/
https://ncbi.nlm.nih.gov/pubmed/18316422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2007.07091440
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi